DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Nomura Maintains Buy on CytomX Therapeutics, Lowers Price Target to $15

Nomura maintains CytomX Therapeutics (NASDAQ:CTMX) with a Buy and lowers the price target from $22 to $15.

Benzinga · 02/28/2020 14:29

Nomura maintains CytomX Therapeutics (NASDAQ:CTMX) with a Buy and lowers the price target from $22 to $15.